•
Sep 30, 2014

Viridian Therapeutics Q3 2014 Earnings Report

Total Revenue
$1.3M
Previous year: $984K
+32.3%
EPS
-$96.8
Previous year: -$4.68
+1969.1%
Gross Profit
$429K
Previous year: $270K
+58.8%

Viridian Therapeutics

Viridian Therapeutics